Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113)

Clinical Biochemistry

Volumn 44, Issue 4, 2011, Pages 281-287

  Indulekha, Karunakaran ^a   Anjana, Ranjith Mohan ^a   Surendar, Jayagopi ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Adiponectin; Diabetes; Hs CRP; Leptin; Oxidized LDL; South Asians; Subcutaneous fat; TNF alpha; Visceral fat; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; DISEASE MARKER; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INDIAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SUBCUTANEOUS FAT;

ABDOMINAL FAT; ADIPOKINES; ADIPONECTIN; ADIPOSITY; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CAUSALITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; LIPOPROTEINS, LDL; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79651469241     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.12.015     Document Type: Article

References (44)

1. DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53(7):1270-1287.
2. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83(2):461S-465S. Review.
3. Murdolo G., Smith U. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis 2006, 16(Suppl 1):S35-S38.
4. Sharp P.S., Mohan V., Levy J.C., Mather H.M., Kohner E.M. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987, 19(2):84-85.
5. Gautier J.F., Mourier A., de Kerviler E., et al. Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance. J Clin Endocrinol Metab 1998, 83(4):1306-1311.
6. Mohan V., Sandeep S., Deepa R., Shah B., Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007, 125(3):217-230.
7. Sandeep S., Gokulakrishnan K., Velmurugan K., Deepa M., Mohan V. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians. Indian J Med Res 2010, 131:629-635.
8. Li F.Y., Cheng K.K., Lam K.S., Vanhoutte P.M., Xu A. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) 2010, Nov 10.
9. Dua A., Hennes M.I., Hoffmann R.G., et al. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996, 45(11):1635-1637.
10. Saddi-Rosa P., Oliveira C.S., Giuffrida F.M., Reis A.F. Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2010, 26(2):21.
11. Ndumele C.E., Pradhan A.D., Ridker P.M. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr 2006, 1(3):190-196.
12. Piché M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005, 96(1):92-97.
13. Patial S., Parameswaran N. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010, 20(2):87-103.
14. Bertin E., Nguyen P., Guenounou M., Durlach V., Potron G., Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diab Metab 2000, 26(3):178-182.
15. Stephens J.W., Khanolkar M.P., Bain S.C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202(2):321-329.
16. Gletsu-Miller N., Hansen J.M., Jones D.P., et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity 2009, 17:439-446.
17. Deepa M., Pradeepa R., Rema M., et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-1). J Assoc Physicians India 2003, 51:863-870.
18. Mohan V., Ravikumar R., Shanthi Rani S., Deepa R. Intimal medial thickness of the carotid artery in south Indian diabetic and nondiabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 1998, 433:494-499.
19. Lonn E., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001, 103:919-925. SECURE Investigators.
20. Anjana M., Sandeep S., Deepa R., Vimaleswaran K.S., Farooq S., Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diab Care 2004, 27(12):2948-2953. Dec.
21. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
22. Raji A., Seely E.W., Arky R.A., Simonson D.C. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001, 86(11):5366-5371.
23. Sam S., Haffner S., Davidson M.H., et al. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diab Care 2009, 32(5):932-937.
24. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29(24):2959-2971.
25. Matsuzawa Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad B Phys Biol Sci 2010, 86(2):131-141.
26. Rui L., Aguirre V., Kim J.K., et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 2001, 107(2):181-189.
27. Fernández-Veledo S., Vila-Bedmar R., Nieto-Vazquez I., Lorenzo M. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab 2009, 94(9):3583-3593.
28. Liew C.F., Seah E.S., Yeo K.P., Lee K.O., Wise S.D. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord 2003, 27(7):784-789.
29. Minocci A., Savia G., Lucantoni R., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000, 24(9):1139-1144.
30. Lorente-Cebrián S., Bustos M., Marti A., Martinez J.A., Moreno-Aliaga M.J. Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin Sci (Lond). 2009, 117(6):243-249.
31. Oki K., Yamane K., Kamei N., Nojima H., Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 2007, 67(5):796-800.
32. Couillard C., Ruel G., Archer W.R., et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 2005, 90(12):6454-6459. Dec.
33. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 2008, 70(3):193-219.
34. Shah A., Mehta N., Reilly M.P. Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr 2008, 32(6):638-644. Review.
35. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102(1):42-47.
36. Cinti S., Mitchell G., Barbatelli G., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46(11):2347-2355.
37. Stefan N., Kantartzis K., Machann J., et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168(15):1609-1616.
38. Hamdy O. The role of adipose tissue as an endocrine gland. Curr Diab Rep 2005, 5(5):317-319.
39. Harman-Boehm I., Blüher M., Redel H., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92(6):2240-2247.
40. Kharbanda R.K., Peters M., Walton B., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001, 103(12):1624-1630.
41. Snijder M.B., Dekker J.M., Visser M., et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003, 77:1192-1197.
42. Miyazaki Y., Mahankali A., Matsuda M., et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002, 87:2784-2791.
43. Tran T.T., Yamamoto Y., Gesta S., Kahn C.R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008, 7(5):410-420. May.
44. Gorgey A.S., Mather K.J., Gater D.R. Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury. Metabolism 2010, Sep 24.